The effectivity of periprostatic nerve blockade for the pain control during transrectal ultrasound guided prostate biopsy


Submitted: June 24, 2013
Accepted: June 24, 2013
Published: June 24, 2013
Abstract Views: 1871
PDF: 1869
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Alper Otunctemur Okmeydani Training and Research Hospital, Department of Urology, Istanbul, Turkey.
  • Murat Dursun Okmeydani Training and Research Hospital, Department of Urology, Istanbul, Turkey.
  • Huseyin Besiroglu Okmeydani Training and Research Hospital, Department of Urology, Istanbul, Turkey.
  • Emre Can Polat Balikligol State Hospital, Department of Urology, Sanliurfa, Turkey.
  • Suleyman Sami Cakir Okmeydani Training and Research Hospital, Department of Urology, Istanbul, Turkey.
  • Emin Ozbek Okmeydani Training and Research Hospital, Department of Urology, Istanbul, Turkey.
  • Tahir Karadeniz Okmeydani Training and Research Hospital, Department of Urology, Istanbul, Turkey.
Aim: Transrectal ultrasound (TRUS) guided prostete biopsy is accepted as a standard procedure in the diagnosis of prostate cancer. Many different protocoles are applied to reduce the pain during the process. In this study we aimed to the comparison of two procedure with intrarectal lidocaine gel and periprostatice nerve blockade respective- ly in addition to perianal intrarectal lidocaine gel on the pain control in prostate biop- sy by TRUS. Methods: 473 patients who underwent prostate biopsy guided TRUS between 2008-2012 were included in the study. 10-point linear visual analog pain scale(VAS) was used to evaluate the pain during biopsy. The patients were divided into two groups according to anesthesia procedure. In Group 1, there were 159 patients who had perianal-intrarectal lidocaine gel, in Group 2 there were 314 patients who had periprostatic nerve blockade in addition to intrarectal lidocain gel. The pain about probe manipulation was aseesed by VAS-1 and during the biopsy needle entries was evalu- ated by VAS-2. Results were compared with Mann-Whitney U and Pearson chi-square test. Results: Mean VAS-2 scores in Group 1 and Group 2 were 4.54 ± 1.02 and 2.06 ± 0.79 respectively. The pain score was determined significantly lower in the Group 2 (p = 0.001). In both groups there was no significant difference in VAS-1 scores, patient’s age, prostate volume, complication rate and PSA level. Conclusion: The combination of periprostatic nerve blockade and intrarectal lidocain gel provides a more meaningful pain relief compared to group of patients undergoing intrarectal lidocaine gel.

Otunctemur, A., Dursun, M., Besiroglu, H., Can Polat, E., Cakir, S. S., Ozbek, E., & Karadeniz, T. (2013). The effectivity of periprostatic nerve blockade for the pain control during transrectal ultrasound guided prostate biopsy. Archivio Italiano Di Urologia E Andrologia, 85(2), 69–72. https://doi.org/10.4081/aiua.2013.2.69

Downloads

Download data is not yet available.

Citations